tocilizumab

The drug is used for the treatment of rheumatoid arthritis (in adults), systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis (in children from 2 years of age), as well as for the treatment of severe COVID-19 in adults receiving corticosteroids who require oxygen support.

Form: concentrate for infusion solution

ATC: L04AC07

Manufacturer: Chugai Pharma Manufacturing Co. Ltd (manufacturing of unpackaged products, primary packaging)

The drug is prescribed for the treatment of rheumatoid arthritis (in adults), polyarticular juvenile idiopathic arthritis (in children from 2 years of age), giant cell arteritis (in adults), and systemic juvenile idiopathic arthritis (in children from 1 year of age).

Form: solution for injection

ATC: L04AC07

Manufacturer: Wetter Pharma-Fertigung GmbH & Co KG (manufacturing of unpackaged products, primary packaging, in-process control, testing for sterility and bacterial endotoxins; testing for sterility and bacterial endotoxins, visual inspection during manufacturing)